Ervin G N, Cooper B R
Department of Pharmacology, Wellcome Research Laboratories, Research Triangle Park, NC 27709.
J Pharmacol Exp Ther. 1988 Apr;245(1):137-46.
Moderate taste aversions were induced by pairing the initial consumption of 0.25% sodium saccharin (SACC) with either 25 mg/kg i.p. l-5-hydroxytryptophan or 30 mg/kg i.p. LiCl. The expression of these moderate conditioned SACC aversions was antagonized by pretreatments (i.p. or p.o.) with benzodiazepine and non-benzodiazepine anxiolytic drugs (lorazepam, diazepam, chlordiazepoxide, oxazepam, phenobarbital, meprobamate, and chlormezanone). Chlordiazepoxide produced less or no antagonism of the expression of stronger SACC aversions induced by 50 or 75 mg/kg l-5-hydroxytryptophan or by 60 or 90 mg/kg LiCl. Nonanxiolytic drugs, including dipsogenic compounds that increased the water intake of hydrated rats (2 M NaCl i.p.; isoproterenol HCl s.c.; and histamine diphosphate s.c.), and even additional 24 hr of fluid deprivation did not antagonize the expression of moderate conditioned taste aversions, indicating that anxiolytic drugs have a very selective effect and that they do not appear to act through homeostatic drinking mechanisms. An essential feature of the taste aversion conflict model is that thirsty rats encounter only SACC. When water was conspicuously available in addition to SACC in two-bottle tests, neither chlordiazepoxide nor phenobarbital antagonized the expression of conditioned taste aversion. Thus, anxiolytic drugs do not produce amnesia for the conditioned aversion, but attenuate the ability of conditioned SACC aversion to suppress SACC consumption in one-bottle tests. The antagonism of the expression of conditioned taste aversion measured with a one-bottle testing method offers a simple, sensitive, and selective screen for anxiolytic drugs. A possible mechanism by which anxiolytics increase both suppressed as well as unsuppressed fluid consumption is discussed.
通过将0.25%的糖精钠(SACC)的初次摄入与25毫克/千克腹腔注射的l-5-羟色氨酸或30毫克/千克腹腔注射的氯化锂配对,诱导出中度味觉厌恶。这些中度条件性SACC厌恶的表现被苯二氮䓬类和非苯二氮䓬类抗焦虑药物(劳拉西泮、地西泮、氯氮卓、奥沙西泮、苯巴比妥、甲丙氨酯和氯美扎酮)的预处理(腹腔注射或口服)所拮抗。氯氮卓对由50或75毫克/千克l-5-羟色氨酸或60或90毫克/千克氯化锂诱导的更强的SACC厌恶的表现产生的拮抗作用较小或没有拮抗作用。非抗焦虑药物,包括增加水合大鼠饮水量的致渴化合物(2摩尔/升腹腔注射氯化钠;皮下注射盐酸异丙肾上腺素;皮下注射磷酸组胺),甚至额外24小时的液体剥夺都没有拮抗中度条件性味觉厌恶的表现,这表明抗焦虑药物具有非常选择性的作用,并且它们似乎不是通过稳态饮水机制起作用。味觉厌恶冲突模型的一个基本特征是口渴的大鼠只接触到SACC。在双瓶试验中,当除了SACC之外明显有饮用水时,氯氮卓和苯巴比妥都没有拮抗条件性味觉厌恶的表现。因此,抗焦虑药物不会对条件性厌恶产生失忆,但会减弱条件性SACC厌恶在单瓶试验中抑制SACC消耗的能力。用单瓶试验方法测量的条件性味觉厌恶表现的拮抗作用为抗焦虑药物提供了一种简单、灵敏和选择性的筛选方法。讨论了抗焦虑药物增加受抑制和未受抑制的液体消耗的一种可能机制。